Plasma total Cysteine and total Homocysteine and Risk of Myocardial Infarction in Women: A prospective study
Open/View files
Date
2010
Author(s)
Page, John H.
Ma, Jing
Chiuve, Stephanie E.
Selhub, Jacob
Manson, JoAnn E.
Rimm, Eric Bruce::0ab2926c8242f35e5a982e3cf59f4987::600
Publisher
Elsevier
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Page, John H., Jing Ma, Stephanie E. Chiuve, Meir J. Stampfer, Jacob Selhub, JoAnn E. Manson, and Eric B. Rimm. 2010. “Plasma Total Cysteine and Total Homocysteine and Risk of Myocardial Infarction in Women: A Prospective Study.” American Heart Journal 159 (4): 599–604. https://doi.org/10.1016/j.ahj.2009.12.037.
Abstract
Background Cysteine is a glutathione precursor, but is also a homocysteine byproduct. We prospectively evaluated relationships between fasting plasma concentrations of total cysteine and total homocysteine, and subsequent myocardial infarction (MI) in women.Methods Among 32,826 women who provided blood samples between 1989 and 1990, 239 were diagnosed with incident MI after blood collection, but before July 1998. Of these women, 144 had provided a postfast sample. We matched controls to cases 2: 1 by age, cigarette smoking status, and month and fasting status at the time of blood collection. We used conditional logistic regression to adjust for confounding.Results Fasting total cysteine was positively related to MI risk in matching factor-adjusted analyses (rate ratio [RR] for highest vs lowest quartile 3.50 [95% CI 1.44-8.52]). However, after controlling for conventional risk factors of MI, it was not independently associated with risk (RR for highest vs lowest quartile 1.32 [95% CI 0.42-4.12, P trend = .10]). Fasting homocysteine was positively associated with MI risk; the multivariable adjusted RR for the highest versus the lowest quartile was 3.37 (95% CI 1.30-8.70, P trend = .014).Conclusions Fasting plasma concentration of total homocysteine, but not total cysteine, was positively associated with MI risk. (Am Heart J 2010; 159: 599-604.)
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
Collection